Kohei Otsubo Selected Research

Sarcoidosis (Schaumann Disease)

1/2020

Immune-checkpoint profiles for T cells in bronchoalveolar lavage fluid of patients with immune-checkpoint inhibitor-related interstitial lung disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kohei Otsubo Research Topics

Disease

20	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2022 - 01/2014
15	Neoplasms (Cancer) 05/2022 - 01/2011
6	Disease Progression 12/2023 - 01/2012
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 03/2024 - 01/2018
4	Idiopathic Pulmonary Fibrosis 12/2023 - 01/2018
3	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2023 - 10/2015
3	Adenocarcinoma of Lung 01/2020 - 10/2015
2	Pneumonia (Pneumonitis) 07/2018 - 09/2017
2	Neoplasm Metastasis (Metastasis) 01/2018 - 01/2012
1	Mediastinitis 03/2024
1	Fistula 03/2024
1	Lung Diseases (Lung Disease) 12/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Overweight 08/2021
1	Diabetes Mellitus 08/2021
1	COVID-19 08/2021
1	Meningeal Carcinomatosis 01/2021
1	Brain Neoplasms (Brain Tumor) 01/2021
1	Dysbiosis 01/2021
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2020
1	Sarcoidosis (Schaumann Disease) 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2019
1	Pleural Effusion (Pleural Effusions) 07/2018
1	Lung Neoplasms (Lung Cancer) 07/2018
1	Hypotension (Low Blood Pressure) 09/2017
1	Anorexia 09/2017
1	Infections 10/2015
1	Dyspnea (Shortness of Breath) 10/2015

Drug/Important Bio-Agent (IBA)

7	Tyrosine Kinase InhibitorsIBA 01/2021 - 09/2017
4	ErbB Receptors (EGF Receptor)IBA 01/2021 - 09/2017
4	Immune Checkpoint InhibitorsIBA 01/2020 - 07/2018
3	PlatinumIBA 12/2018 - 01/2016
3	130-nm albumin-bound paclitaxelIBA 07/2018 - 01/2016
3	Carboplatin (JM8)FDA LinkGeneric 07/2018 - 01/2012
2	Anti-Bacterial Agents (Antibiotics)IBA 03/2024 - 01/2022
2	nintedanibIBA 12/2022 - 01/2018
2	Etoposide (VP 16)FDA LinkGeneric 12/2018 - 07/2018
2	Paclitaxel (Taxol)FDA LinkGeneric 07/2018 - 01/2012
1	Antifibrotic AgentsIBA 12/2023
1	Connective Tissue Growth FactorIBA 12/2023
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2023
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2022
1	B7-H1 AntigenIBA 02/2022
1	Ferritins (Ferritin)IBA 08/2021
1	dacomitinibIBA 01/2021
1	Phosphotransferases (Kinase)IBA 10/2020
1	RNA (Ribonucleic Acid)IBA 07/2020
1	DNA (Deoxyribonucleic Acid)IBA 07/2020
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020
1	Immune Checkpoint ProteinsIBA 01/2020
1	osimertinibIBA 01/2020
1	Antinuclear AntibodiesIBA 01/2019
1	Circulating Tumor DNAIBA 01/2019
1	AntibodiesIBA 01/2019
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 07/2018
1	Complementarity Determining Regions (Complementarity Determining Region)IBA 07/2018
1	NivolumabIBA 07/2018
1	Albumin-Bound Paclitaxel FDA Link 01/2018
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2018
1	LigandsIBA 01/2018
1	trkB ReceptorIBA 01/2018
1	AfatinibIBA 09/2017
1	Cisplatin (Platino)FDA LinkGeneric 09/2017
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 09/2017
1	Aspartic Acid (Aspartate)FDA Link 09/2017
1	Protein Isoforms (Isoforms)IBA 09/2017
1	Alanine Transaminase (SGPT)IBA 09/2017
1	Pemetrexed (MTA)FDA Link 09/2017
1	alectinibIBA 10/2015
1	Anaplastic Lymphoma KinaseIBA 10/2015
1	Proteins (Proteins, Gene)FDA Link 01/2014
1	Messenger RNA (mRNA)IBA 01/2014
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2012

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 12/2022 - 01/2011
3	Therapeutics 05/2022 - 07/2018
2	Immunotherapy 05/2022 - 01/2021
1	Chemoradiotherapy 03/2024
1	Aftercare (After-Treatment) 01/2020
1	Ligation 09/2017